Molecular docking studies represent a cornerstone in modern drug discovery by providing detailed insights into the specific interactions between bioactive compounds and target enzymes. This ...
Although CABG remains the revascularization treatment of choice for patients with severely symptomatic or life-threatening coronary artery disease (CAD), 9% to 25% of the patients who have undergone ...